Compare NMP & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NMP | CGTX |
|---|---|---|
| Founded | 2024 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 158.8M |
| IPO Year | 2025 | 2021 |
| Metric | NMP | CGTX |
|---|---|---|
| Price | $10.00 | $1.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 59.2K | ★ 978.2K |
| Earning Date | 01-01-0001 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.90 | $0.22 |
| 52 Week High | $10.07 | $3.83 |
| Indicator | NMP | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 54.36 |
| Support Level | N/A | $1.58 |
| Resistance Level | N/A | $1.81 |
| Average True Range (ATR) | 0.00 | 0.13 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 82.30 |
NMP Acquisition Corp is a blank check company.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.